STEALTH BIOTHERAPEUTICS CORP (MITO)       0.3108  +0 (+0.13%)

0.3108  +0 (+0.13%)

US85789A1051 - ADR - After market: 0.3175 +0.01 (+2.16%)

News Image
4 days ago - STEALTH BIOTHERAPEUTICS INC.

Stealth BioTherapeutics Announces Departure of Chief Financial Officer

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization...

News Image
19 days ago - STEALTH BIOTHERAPEUTICS INC.

Stealth BioTherapeutics to Participate in Upcoming Ultra-Rare Disease Events

/PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development, and...

News Image
3 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Good morning, traders! Investors seeking news of the biggest pre-market stock movers for Tuesday are in the right place.

News Image
3 months ago - STEALTH BIOTHERAPEUTICS INC.

STEALTH BIOTHERAPEUTICS ANNOUNCES RECEIPT OF NON-COMPLIANCE NOTICE FROM NASDAQ

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization...

News Image
3 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Good morning, trader! With the start of another day comes our breakdown of the biggest pre-market stock movers for Wednesday!

News Image
3 months ago - STEALTH BIOTHERAPEUTICS INC.

Stealth BioTherapeutics Corp Announces Receipt of Preliminary Non-Binding Proposal

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and...

News Image
4 months ago - STEALTH BIOTHERAPEUTICS INC.

Stealth BioTherapeutics Granted Pre-NDA Meeting for Elamipretide as a Potential Treatment for Barth Syndrome

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization...

News Image
4 months ago - STEALTH BIOTHERAPEUTICS INC.

Stealth BioTherapeutics Presents New SBT-272 Data Demonstrating Improvement in Upper Motor Neuron Function in ALS Disease Model at Keystone Neurodegeneration Symposium

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and...